Study Results from SAIC-Frederick in the Area of Nanomedicine Published

2011 OCT 18 -- Investigators publish new data in the report "Translational considerations for cancer nanomedicine." According to the authors of recent research from Frederick, Maryland, "There are many important considerations during preclinical development of cancer nanomedicines, including: 1) unique aspects of animal study design; 2) the difficulties in evaluating biological potency, especially for complex formulations; 3) the importance of analytical methods that can determine platform stability in vivo, and differentiate bound and free active pharmaceutical ingredient (API) in biological matrices; and 4) the appropriateness of current dose scaling techniques for...

Want to see the full article?

• Purchase this article for only $3.00